DAFTAR PUSTAKA

American Diabetes Association. 2011. Standards of Medical Care in

Diabetes.Diabetes Care. (24) pp.S11-S61.
Annemans, L., Nadia Demarteau, (2008). "An Asian Regional Analysis of CostEffectiveness of Early Irbesartan Treatment versus Conventional
Antihypertensive, Late Amlodipine, and Late Irbesartan Treatments in
Patients with Type 2 Diabetes, Hypertension, and Nephropathy." Value In
Health II Nomer 3: 354-364
Balakumar, P., Mandeep Kumar Arora, Manjeet Singh (2009). "Emerging role of
PPAR ligands in the management of diabetic nephropathy."
Pharmacological Research
Fauci, A. S., Braunwald Eugene, Kasper Dennis, Hauser Stephen, Longo, Larry
Jameson, Joseph Loscalzo. (2008). Harrison's Principles Of Internal
Medicine Seventeenth Edition. United States of America, The McGrawHill Companies.
Haffner, S.M. et al. 1998. N Engl J Med;339:229234.
Nurtanio, N., Sunny, W., 2007. Resistensi Insulin pada Obesitas Sentral. BIK
Biomed, Vol. 3 (3), pp.89-96.
Notoatmodjo. S, 2003. Ilmu Kesehatan Masyarakat. Jakarta: Rineka Cipta.
PerkumpulanEndokrinologi Indonesia (PERKENI). 2006. Diabetes The Silent
Killer.
Powers, A.C., 2005. Diabetes Mellitus dalam D.L. Kasper, A.S. Fauci, D.L.
Longo, E. Braunwald, S.L. Hauser, J.L Jameson, (eds). Harrisons
Priciples of Internal Medicine. 16th ed, McGraw-Hill Medical Publishing
Division, New York: pp.2152-80.
Report of a WHO/IDF Consultation, Geneva, Switzerland.
Wajchenberg, B.L., 2000. Subcutaneous and Visceral Adipose Tissue: Their
relation to the metabolic syndrome. Endoc Rev 2002; 21 (6), pp.697-738.
Waspadji, Sarwono. 2004. PengelolaanFarmakologisDiabetesMellitus yang
RasionaldalamBuku Ajar IlmuPenyakitDalamJilid I Edisi III. Jakarta:
BalaiPenerbit FKUI: pp.648-54

WHO, 2006. Definition and Diagnosis of Diabetes Mellitus and Intermediate

Hyperglycemia.